Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: RESEARCH TRIANGLE INSTITUTE
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-26 to 2023-09-29
Current total value of award: $899795
Description: EO14042 ASSESSING WHETHER DRUG DISCRIMINATION SELECTIVELY EVALUATES PHARMACOLOGICAL MECHANISMS OF ACTION